Chemours (CC) Misses Q1 EPS by 10c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
Chemours (CC) PT Lowered to $11.50 at Jefferies
May 8, 2025 12:55 PM EDTJefferies analyst Laurence Alexander lowered the price target on Chemours (NYSE: CC) to $11.50 (from $20.00) while maintaining a Hold rating.
The analyst comments "Q1 EPS of $0.13 was $0.07 below consensus and $0.21 below our estimate. Supply chain distortions appear to be a near-term headwind, while a... More
